TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/31/23 16:17 | 1/27/23 | OPNT | Opiant Pharmaceuticals, Inc. | Health | Drug | Pharmaceutical Preparations | O'Toole David D | CA | O | CFO | S | -11 | 20.26 | 0 | -1 | -2 | 34 | D | |||||||||||||||
1/9/23 17:16 | 1/9/23 | OPNT | Opiant Pharmaceuticals, Inc. | Health | Drug | Pharmaceutical Preparations | O'Toole David D | CA | O | CFO | S | -8 | 20.20 | 0 | 0 | -1 | 35 | D | |||||||||||||||
1/5/23 17:03 | 1/5/23 | OPNT | Opiant Pharmaceuticals, Inc. | Health | Drug | Pharmaceutical Preparations | O'Toole David D | CA | O | CFO | S | -32 | 20.20 | 0 | -2 | -4 | 35 | D | |||||||||||||||
7/15/22 16:06 | 7/14/22 | OPNT | Opiant Pharmaceuticals, Inc. | Health | Drug | Pharmaceutical Preparations | O'Toole David D | CA | O | CFO | S | -9 | 11.10 | 0 | -1 | -2 | 37 | D | |||||||||||||||
1/12/22 16:39 | 1/10/22 | OPNT | Opiant Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | O'Toole David D | CA | O | CFO | S | -13 | 30.60 | 0 | 0 | -1 | 36 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |